Cargando…
Prognostic Performance of Inflammatory Biomarkers Based on Complete Blood Counts in COVID-19 Patients
With the end of the pandemic, COVID-19 has entered an endemic phase with expected seasonal spikes. Consequently, the implementation of easily accessible prognostic biomarkers for patients with COVID-19 remains an important area of research. In this monocentric study at a German tertiary care hospita...
Autores principales: | Gambichler, Thilo, Schuleit, Nadine, Susok, Laura, Becker, Jürgen C., Scheel, Christina H., Torres-Reyes, Christian, Overheu, Oliver, Reinacher-Schick, Anke, Schmidt, Wolfgang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536301/ https://www.ncbi.nlm.nih.gov/pubmed/37766326 http://dx.doi.org/10.3390/v15091920 |
Ejemplares similares
-
Evans’ syndrome following vaccination with ChAdOx1 nCoV-19 in a patient with new-onset localized scleroderma
por: Gambichler, Thilo, et al.
Publicado: (2022) -
Cancer and Immune Checkpoint Inhibitor Treatment in the Era of SARS-CoV-2 Infection
por: Gambichler, Thilo, et al.
Publicado: (2020) -
Prognostic Potential of the Baseline Pan-Immune-Inflammation Value and Neutrophil/Lymphocyte Ratio in Stage I to III Melanoma Patients
por: Gambichler, Thilo, et al.
Publicado: (2022) -
The Antineoplastic Effect of Dimethyl Fumarate on Virus-Negative Merkel Cell Carcinoma Cell Lines: Preliminary Results
por: Gambichler, Thilo, et al.
Publicado: (2023) -
Waiving Subsequent Complete Lymph Node Dissection in Melanoma Patients with Positive Sentinel Lymph Node Does Not Result in Worse Outcome on 20-Year Analysis
por: Susok, Laura, et al.
Publicado: (2021)